Cell Source Inc (CE) (CLCS)
USOTC
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
We are engaged in the development and commercialization of the patented technology which we license. We are currently sponsoring a clinical trial in the US. Our principal operations are focused on developing innovative cell therapy products focused on the treatment of blood cancers and nonmalignant ... We are engaged in the development and commercialization of the patented technology which we license. We are currently sponsoring a clinical trial in the US. Our principal operations are focused on developing innovative cell therapy products focused on the treatment of blood cancers and nonmalignant blood disorders as well as the facilitation of safer and more accessible organ transplantations. Show more
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0.0008 | 0.0008 | 0.0008 | 119 | 0.0008 | CS |
| 26 | -0.4892 | -99.8367346939 | 0.49 | 0.63 | 0.0002 | 10880 | 0.40752724 | CS |
| 52 | -0.5892 | -99.8644067797 | 0.59 | 0.74 | 0.0002 | 14047 | 0.48772626 | CS |
| 156 | -1.8892 | -99.9576719577 | 1.89 | 1.98 | 0.0002 | 9646 | 0.62319856 | CS |
| 260 | -0.5692 | -99.8596491228 | 0.57 | 2.55 | 0.0002 | 8093 | 0.85429159 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
